Using disease management and market reforms to address the adverse economic effects of drug budgets and price and reimbursement regulations in Germany. [electronic resource]
Producer: 20030829Description: S20-30 p. digitalISSN:- 1098-3015
- Budgets
- Cost Control
- Cost-Benefit Analysis
- Disease Management
- Drug Costs -- trends
- Drug Utilization -- economics
- Economics, Pharmaceutical
- Germany
- Health Benefit Plans, Employee -- legislation & jurisprudence
- Health Care Reform -- legislation & jurisprudence
- Health Care Sector -- legislation & jurisprudence
- Health Expenditures -- trends
- Humans
- Insurance, Pharmaceutical Services -- legislation & jurisprudence
- National Health Programs -- economics
- Regional Health Planning -- economics
- Technology Assessment, Biomedical
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.